Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder.
Hansmann H, Henkel C, Fante MA, Harrer DC, Heidemanns S, Oellerich M, Beck J, Schütz E, Biswenger V, Perl M, Zartner B, Edinger M, Wolff D, Hoffmann P, Herr W, Banas B, Zecher D, Hansmann L.
Hansmann H, et al. Among authors: perl m.
Am J Transplant. 2025 Sep 17:S1600-6135(25)02986-7. doi: 10.1016/j.ajt.2025.09.009. Online ahead of print.
Am J Transplant. 2025.
PMID: 40972901
Free article.